Wilson Sonsini Goodrich & Rosati and Goodwin advised MiroBio on the deal.MiroBio, a leader in the development of checkpoint agonists to treat autoimmune diseases, announced the…
MiroBio’s $97 Million Series B Financing


Wilson Sonsini Goodrich & Rosati and Goodwin advised MiroBio on the deal.MiroBio, a leader in the development of checkpoint agonists to treat autoimmune diseases, announced the…
…